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ABSTRACT Measles is characterized by a transient immune suppression, leading to
an increased risk of opportunistic infections. Measles virus (MV) infection of immune
cells is mediated by the cellular receptor CD150, expressed by subsets of lympho-
cytes, dendritic cells, macrophages, and thymocytes. Previous studies showed that
human and nonhuman primate memory T cells express higher levels of CD150 than
naive cells and are more susceptible to MV infection. However, limited information is
available about the CD150 expression and relative susceptibility to MV infection of
B-cell subsets. In this study, we assessed the susceptibility and permissiveness of na-
ive and memory T- and B-cell subsets from human peripheral blood or tonsils to in
vitro MV infection. Our study demonstrates that naive and memory B cells express
CD150, but at lower frequencies than memory T cells. Nevertheless, both naive and
memory B cells proved to be highly permissive to MV infection. Furthermore, we as-
sessed the susceptibility and permissiveness of various functionally distinct T and B
cells, such as helper T (TH) cell subsets and IgG- and IgA-positive memory B cells, in
peripheral blood and tonsils. We demonstrated that TH1TH17 cells and plasma and
germinal center B cells were the subsets most susceptible and permissive to MV in-
fection. Our study suggests that both naive and memory B cells, along with several
other antigen-experienced lymphocytes, are important target cells of MV infection.
Depletion of these cells potentially contributes to the pathogenesis of measles im-
mune suppression.
IMPORTANCE Measles is associated with immune suppression and is often compli-
cated by bacterial pneumonia, otitis media, or gastroenteritis. Measles virus infects
antigen-presenting cells and T and B cells, and depletion of these cells may contrib-
ute to lymphopenia and immune suppression. Measles has been associated with fol-
licular exhaustion in lymphoid tissues in humans and nonhuman primates, empha-
sizing the importance of MV infection of B cells in vivo. However, information on the
relative susceptibility of B-cell subsets is scarce. Here, we compared the susceptibility
and permissiveness to in vitro MV infection of human naive and memory T- and
B-cell subsets isolated from peripheral blood or tonsils. Our results demonstrate that
both naive and memory B cells are more permissive to MV infection than T cells.
The highest infection levels were detected in plasma cells and germinal center B
cells, suggesting that infection and depletion of these populations contribute to re-
duced host resistance.
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Measles virus (MV) is an enveloped virus with a single-stranded negative-senseRNA genome that belongs to the family Paramyxoviridae, genus Morbillivirus.
This highly contagious virus is transmitted via the respiratory route and causes
systemic disease in humans and nonhuman primates (NHPs). Measles is character-
ized by fever, cough, and skin rash (1, 2). The hallmark of the disease is a transient
immune suppression, which leads to increased susceptibility to opportunistic in-
fections (3). Common complications include bacterial pneumonia, otitis media, or
diarrhea. Despite the availability of safe and effective live-attenuated vaccines (4),
measles remains an important cause of global childhood mortality. In 2016, more
than 85,000 people, mostly children below the age of 5 years, died due to measles
and its sequelae (5).
Measles virus is an intrinsically dual-tropic virus that uses two different cellular entry
receptors (6). Infection of immune cells is mediated by CD150, a member of the
signaling lymphocytic activation molecule (SLAM) family. CD150 is expressed by sub-
sets of T and B cells, dendritic cells (DCs), macrophages, thymocytes, and hematopoietic
stem cells and mediates the entry and dissemination of MV (7–9). Infection of epithelial
cells is mediated by nectin-4 and is considered of crucial importance for virus trans-
mission (10, 11).
Measles is associated not only with immune suppression but also with a paradoxical
immune activation (12, 13). Uncomplicated measles in children with a functional
immune system is typically a self-limiting disease, and recovery is attributed to strong
MV-speciﬁc immune responses that confer lifelong immunity. Lymphopenia is common
during the acute stage of measles and lasts for about 1 week, whereas immune
suppression can last for several weeks, months, or even years (3, 14, 15). Shortly after
clearance of MV-infected cells by the host cellular immune response, the numbers of
circulating lymphocytes return to normal. On the basis of these observations, a model
was postulated to explain measles-induced immune suppression: preexisting CD150
memory lymphocytes are depleted during MV infection, resulting in a temporary
immunological amnesia. The depletion of CD150 cells is masked by the expansion of
MV-speciﬁc and bystander lymphocytes (14, 16).
MV also infects and replicates in B cells (17–22). Studies in humans and NHPs have
shown that MV infects B-cell follicles in lymphoid tissues and causes follicular exhaus-
tion during and shortly after the peak of viremia in humans and macaques (14, 17, 18,
23, 24). For a successful viral infection, cells must be accessible, susceptible, and
permissive. Susceptible cells express receptors on the cell surface that allow entry of the
virus, while permissive cells can support viral replication (25). Multiple subsets of B cells
are known to express and upregulate the expression of CD150 on their surfaces upon
maturation, development, and differentiation (14, 26), but their relative susceptibility to
MV has not yet been described. Given the importance of CD150 in MV infection and the
lack of a complete understanding of the interaction between MV and speciﬁc lympho-
cyte subsets, we investigated the relative susceptibility of human peripheral blood and
tonsillar T- and B-cell subsets to in vitro MV infection. We demonstrate that both naive
and memory B cells are susceptible and permissive to in vitro MV infection.
RESULTS
Lower frequency of CD150 cells in peripheral blood B cells than in T cells. We
determined the frequencies of T and B cells and their subsets (as deﬁned in Table 1) in
peripheral blood mononuclear cells (PBMC) of healthy adult donors (Fig. 1A to D), as
well as the frequencies of cells expressing CD150 in each of these populations (Fig. 1E
to H). Previous studies have shown that CD4 and CD8 memory T cells expressed
higher levels of CD150 than their naive counterparts (14, 24). Consistent with these
ﬁndings, we found that within the CD4 and CD8 T-cell subsets, more memory than
naive T cells expressed CD150 (Fig. 1F and G). B cells contained fewer cells that
expressed CD150 (Fig. 1E), and, in contrast to T cells, the frequencies of CD150 cells
in the naive B-cell subset were signiﬁcantly higher than those in the memory subsets
(Fig. 1H).
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Higher frequency of MV-infected cells in peripheral blood B cells than in T cells.
Next, we evaluated the permissiveness of the T- and B-cell subsets described above
after in vitro MV infection. MV dissemination in vivo is mostly mediated by direct
cell-to-cell transmission of virus. To mimic this process, freshly isolated PBMC (n 
6 donors) were cocultured with cells of a rMVKSVenus(3)-infected autologous
B-lymphoblastoid cell line (BLCL) (27). In these experiments, expression of the
ﬂuorescent reporter protein Venus was used to identify MV-infected cells. We
validated these experiments with wild-type MV strain MVi/Amsterdam.NLD/19.11
(n  4 donors) and identiﬁed the wild-type MV-infected cells using intracellular
staining of the virus nucleoprotein (NP). To assess the levels of MV-infected cells
from the ﬁrst round of infection, we determined the percentages of infected cells
after 30 h of coculture (Fig. 1I to L). In accordance with the ﬁndings of previous
studies (14, 24), we found that within the T-cell populations, MV preferentially
infected CD4 and CD8 memory T cells (Fig. 1J and K). Surprisingly, despite the
lower percentage of CD150-expressing cells, a higher frequency of MV-infected cells
was found among B cells than CD4 and CD8 T cells (Fig. 1I). Moreover, in B-cell
populations, despite the higher frequency of CD150 cells within the naive cells
than within the memory cells, there was no preferential infection of naive B cells,
as all subsets were susceptible and permissive to MV infection (Fig. 1L).
Since autologous BLCL were not always available for coculture, we also inoculated
the freshly isolated PBMC with cell-free rMVKSVenus(3) or wild-type MV strain MVi/
Amsterdam.NLD/19.11 at multiplicity of infection (MOI) of 1 in the presence of
infection-enhancing lipopeptide (Fig. 1M). The susceptibility and permissiveness pat-
TABLE 1 Deﬁnition of peripheral blood and tonsillar lymphocyte subsetsa
Subset name Deﬁnition
T cells CD3
CD4 T cells CD3 TCR CD4 CD8
Naive cells CD3 TCR CD4 CD8 CD45RA CCR7 CD27
Memory cells
TCM CD3 TCR CD4 CD8 CD45RA CCR7 CD27
TEMRO CD3 TCR CD4 CD8 CD45RA CCR7
TEMRA CD3 TCR CD4 CD8 CD45RA CCR7
TFH CD3 TCR CD4 CD8 CD45RA CXCR5
TH1 CD3 CD4 CD8 CD45RA CD25low CCR6 CXCR3 CCR4
TH2 CD3 CD4 CD8 CD45RA CD25low CCR6 CXCR3 CCR4
TH1TH17 CD3 CD4 CD8 CD45RA CD25low CCR6 CXCR3 CCR4
TH17 CD3 CD4 CD8 CD45RA CD25low CCR6 CXCR3 CCR4
Treg CD3 CD4 CD8 CD45RA CD25high CD127/low
CD8 T cells CD3 TCR CD4 CD8
Naive cells CD3 TCR CD4 CD8 CD45RA CCR7 CD27
Memory cells
TCM CD3 TCR CD4 CD8 CD45RA CCR7 CD27
TEMRO CD3 TCR CD4 CD8 CD45RA CCR7
TEMRA CD3 TCR CD4 CD8 CD45RA CCR7
B cells CD19
Transitional CD19 CD21high CD24 CD27 CD38
Plasma cells CD19 CD21high CD24 CD27 CD38
GC cells CD19 CD21high CD24 CD38high
Naive cells CD19 CD21high CD38low CD27 IgM
Memory cells
IgM/non-CSM cells CD19 CD21high CD38low CD27 IgM
IgM-only cells CD19 CD21high CD38low CD27 IgM IgD
Natural effector CD19 CD21high CD38low CD27 IgM IgD
CSM B cells CD19 CD21high CD38low CD27/ IgM
IgG cells CD19 CD21high CD38low CD27/ IgM IgD IgA IgG
IgA cells CD19 CD21high CD38low CD27/ IgM IgD IgA IgG
aTCM, central memory T cells; TEMRO/TEMRA, CD45RO/CD45RA effector memory T cells; TFH, follicular helper
T cells; TH, helper T cells; Treg, regulatory T cells; non-CSM, non-class-switched memory; CSM, class-switched
memory; GC, germinal center.
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terns of CD4 and CD8 memory T cells and B cells were largely reproduced in this
cell-free inoculation (Fig. 1N to P).
MV preferentially infects tonsillar B cells. PBMC contain a relatively low percent-
age of B cells (4 to 14%; Fig. 1A). Some B-cell subsets, including germinal center (GC)
B cells and plasma cells, do not circulate at substantial levels. Moreover, MV replicates
ﬁrst and foremost in lymphoid tissues in vivo. Thus, we validated our ﬁndings using
single-cell suspensions from human tonsils, of which 42 to 59% consisted of B cells (Fig.
2A). Lymphocyte subsets (Fig. 2B to D) and the frequencies of CD150 cells (Fig. 2E to
H) were deﬁned and determined as described above for PBMC. CD150 cells were more
frequent within the tonsillar memory CD4 and CD8 T cells than within their naive
counterparts (Fig. 2F to G). Between the tonsillar naive and memory B cells, the fractions
of CD150 cells were not signiﬁcantly different (Fig. 2H). Upon in vitro cell-free
inoculation with MV, B cells had a higher frequency of MV-infected cells than T cells
(Fig. 2I). Still in accordance with previous ﬁndings (14), tonsillar memory T cells within
both the CD4 and CD8 subsets were preferentially infected compared to naive T
cells (Fig. 2J to K). Within the tonsillar B-cell subsets, this preferential infection of naive
or memory cells was not observed (Fig. 2L).
Functionally distinct T- and B-cell subsets have different MV infection levels.
Several T- and B-cell subsets have been described to have distinct functions in the
immune response to pathogens. We determined the frequencies of CD150 cells within
FIG 1 Susceptibility and permissiveness of human peripheral blood T- and B-cell subsets to in vitro MV infection. Human PBMC (n  10 donors) were gated
into CD4 and CD8 T cells and B cells and further subtyped into naive and memory cells. (A to D) Frequencies of T cells, B cells, and their subsets in blood
PBMC; (E to H) frequencies of CD150 cells within T- and B-cell subsets; (I to L) frequencies of MV-infected PBMC following 30 h of coculture with autologous
MV-infected BLCL; (M to P) frequencies of MV-infected PBMC following cell-free inoculation. IgMm, IgM memory B cells; CD27m, CD27 memory B cells;
CD27m, CD27 memory B cells. Data are presented as box plots. *, P  0.05; **, P  0.01; ***, P  0.001.
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a number of circulating CD4 T-cell subsets, follicular helper T cells (TFH cells), helper
T cells (TH1, TH2, TH17, and TH1TH17 cells), and regulatory T cells (Treg cells) (Fig. 3A),
and assessed their MV infection levels. TFH cells are a speciﬁc effector helper T-cell
subset responsible for the interaction with B cells in the GC. This population resides in
the lymph nodes, although a fraction of the cells could be found circulating in blood
as well (Fig. 3A). TFH cells express various SLAM family members (9). In this study, we
observed that a median of 52% of circulating TFH cells expressed CD150, but only a
median of 2 or 6% of TFH cells was infected following BLCL coculture or cell-free
infection, respectively. Other important effector subsets include the TH1 and TH2 cells.
In accordance with the ﬁndings of previous studies reporting a higher CD150 mRNA
level in TH1 cells than in TH2 cells (28), we found more CD150 TH1 cells (median, 78%)
than CD150 TH2 cells (median, 61%). Despite these high percentages of susceptible
cells, infection levels were consistently below 20% of the respective subsets. Treg cells
showed a similar pattern with a median of 65% CD150 cells but less than 25%
MV-infected cells. The CCR6 TH17 and TH1TH17 cell subsets contained the highest
frequencies of CD150 and MV-infected cells within the T-cell compartment.
We next assessed the expression of CD150 on further deﬁned circulating B-cell
subsets, transitional, non-class-switched IgM-positive (IgM) memory (IgM-only and
natural effector B-cell) subsets, class-switched CD27 IgM-negative (IgM) and CD27
IgM memory (IgG and IgA) subsets, and plasma cells, and also their MV infection
levels. CD150 and MV-infected cells were found at high frequencies among transi-
tional, IgG memory, and plasma cells (Fig. 3B).
Studies in macaques inoculated with recombinant MV expressing enhanced green
ﬂuorescence protein showed that MV-infected cells migrate from the site of inoculation
into the draining lymph nodes and rapidly infect susceptible lymphocytes, resulting in
T- and B-cell depletion in the lymphoid tissues (14). Nonetheless, the susceptible
subsets of these tissue lymphocytes have been deﬁned only rudimentarily. To gain
FIG 2 Susceptibility and permissiveness of human tonsillar T- and B-cell subsets to in vitroMV infection. Human tonsillar lymphocytes (n 3 donors) were gated
into CD4 and CD8 T cells and B cells and further subtyped into naive and memory cells. (A to D) Frequencies of human tonsillar T cells, B cells, and their
subsets; (E to H) frequencies of CD150 cells within T- and B-cell subsets; (I to L) frequencies of MV-infected tonsillar lymphocytes following cell-free inoculation.
IgMm, IgM memory B cells; CD27m, CD27 memory B cells; CD27m, CD27 memory B cells. Data are presented as box plots. *, P  0.05.
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FIG 3 Susceptibility and permissiveness of speciﬁc effector T- and B-cells in peripheral blood (n 10 donors) and tonsils
(n  3). The frequencies of T- and B-cell effector subsets in blood PBMC (A and B) or tonsils (C and D), the frequencies
(Continued on next page)
Laksono et al. Journal of Virology
April 2018 Volume 92 Issue 8 e00131-18 jvi.asm.org 6
more insight into this, we investigated speciﬁc human tonsillar T- and B-cell subsets for
their frequencies of CD150 and MV-infected cells. Similar to the circulating T-cell
population, the highest frequencies of CD150 and MV-infected cells were found
among the TH1TH17 cell subset. Surprisingly, tonsillar Treg cells had a lower frequency
of CD150 cells but a higher frequency of MV-infected cells than their peripheral blood
equivalents (Fig. 3C). Among tonsillar B-cell subsets, IgG and IgA memory cells had
comparable frequencies of CD150 cells and MV-infected cells. A speciﬁc B-cell subset
known as GC B cells was present in high numbers in lymphoid tissues, but not in the
circulation (29). Although the frequency of CD150 cells in this subset was relatively
low, they had the highest frequency of MV-infected cells (Fig. 3D).
MV-infected B cells produce infectious virus. Infection of cells with a Venus-
expressing recombinant MV can be assessed by measuring the percentage of Venus-
positive (Venus) cells or by determining the number of infected cells capable of
transmitting the virus to new susceptible cells. We obtained puriﬁed naive and memory
CD4 T- and B-cell subsets from human PBMC by ﬂuorescence-activated cell sorting
(FACS) (Table 2) and inoculated each subset with rMVKSVenus(3) at an MOI of 3 in the
presence of infection-enhancing lipopeptide. After 24 h, the infection percentages in
the sorted subsets were determined by ﬂow cytometry. In accordance with previous
ﬁndings, the frequency of infected cells in CD4 T-cell subsets, deﬁned as Venus cells,
was found to be lower in sorted naive T cells than in the memory cells. Among the
B-cell subsets, the frequency of infected cells in sorted naive cells was comparable to
that in the memory cells (Fig. 4A).
To assess the capability of MV-infected cells to produce new infectious virus
particles, we assessed the numbers of MV-infected sorted cells that can infect new,
susceptible cells. MV-infected sorted naive T cells, being the least susceptible subset to
MV infection, gave rise to a lower number of newly infected cells than memory T cells.
Surprisingly, despite the comparable susceptibility of naive and memory B cells to MV
infection, MV-infected sorted memory B cells generated a higher frequency of infected
cells than naive cells (Fig. 4B). We veriﬁed these ﬁndings in sorted tonsillar lymphocytes.
Naive T cells were less susceptible to MV infection and had a lower frequency of
productive infected cells than memory T cells. In accordance with their peripheral blood
counterparts, tonsillar naive and memory B cells were highly susceptible to MV infec-
tion (Fig. 4C). However, in contrast to circulating B cells, the number of productive
infected tonsillar naive B cells was as high as that of memory B cells (Fig. 4D).
Altogether, these ﬁndings demonstrate that both naive and memory B cells are
susceptible and permissive to MV infection, and their infection leads to dissemination
of infectious virus.
DISCUSSION
In this study, we have directly compared the susceptibility and permissiveness of
human lymphocyte subsets to in vitro MV infection. Our results were compliant with
previous observations, in which memory T cells were more susceptible than their naive
counterparts. Although the frequencies of CD150-expressing B cells were lower than (in
FIG 3 Legend (Continued)
of CD150 cells within the subsets, and the frequencies of MV-infected cells following either 30 h of coculture with
autologous MV-producing BLCL or cell-free inoculation of MV are shown. Nat. eff., natural effector; IgMm, IgM
memory B cells. Data are presented as box plots.
TABLE 2 Deﬁnition of sorted peripheral blood and tonsillar lymphocyte subsetsa
Subset name Deﬁnition
CD4 TN CD3 CD19 CD4 CD8 CD45RO CCR7
CD4 TM CD3 CD19 CD4 CD8 CD45RO CCR7
BN CD19 CD38low CD27 IgM
BM CD19 CD38low CD27 IgM
aTN, naive T cells; TM, memory T cells; BN, naive B cells; BM, memory B cells.
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blood) or comparable to (in tonsils) those of T cells, both naive and memory B cells
showed substantially higher in vitro MV infection levels, suggesting that B cells are
more permissive to MV infection than T cells. Direct comparison of functionally distinct
T- and B-cell subsets identiﬁed TH1TH17 cells, plasma cells, and GC B cells to be subsets
highly susceptible and permissive to MV infection.
Previous studies have identiﬁed alveolar macrophages and DCs to be the initial
target cells of MV. These cells migrate to the draining lymphoid tissues, where they
come in contact with susceptible CD150 T and B cells (30), resulting in cell-associated
viremia and viral dissemination to all lymphoid tissues. To understand the impact of MV
infection on the immune system, it is important to assess differences in the suscepti-
bility and permissiveness of lymphocyte subsets. Although several studies have shown
the higher susceptibility of memory T cells than naive T cells, information on differences
in susceptibility and the permissiveness of B-cell subsets was limited.
In this study, we included naive and memory T-cell subsets as internal controls to
validate our in vitro infection model. After we conﬁrmed that memory T cells have
higher susceptibility than naive T cells to MV infection, as previously described, we
expanded our observations to include T-cell subsets with speciﬁc effector functions,
since their depletion may contribute to measles immune suppression. Among these are
TFH cells, which constitute a major fraction of the lymphoid tissue T-cell population and
secrete cytokines that are critical for induction of B-cell proliferation, isotype switching,
and antibody secretion. Other helper T (TH) cell subsets, such as TH1, TH2, TH17,
TH1TH17, and Treg cells, have also been reported to play crucial effector roles during
the immune responses against various pathogens (31, 32). Interestingly, we observed
a relatively high susceptibility and permissiveness of TH17 and TH1TH17 cell subsets.
TH17 cells have been reported to disrupt the blood-brain barrier (BBB) and promote the
FIG 4 Susceptibility and permissiveness (determined by ﬂow cytometry) and number of productive infected sorted peripheral blood (A
and B) or tonsillar (C and D) naive and memory CD4 T and B cells (determined by virus isolation). Sorted naive and memory B cells
retained their susceptibility to MV infection, despite the absence of other lymphocytes, suggesting that this is an intrinsic characteristic
of the cells. When these infected cells were cocultured with susceptible cells, it resulted in a high number of newly infected cells. TN, CD4
naive T cells; TM, CD4 memory T cells; BN, naive B cells; BM, memory B cells. *, P  0.05.
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recruitment of white blood cells into the central nervous system (CNS), while TH1TH17
cells were demonstrated to migrate across the BBB (32). Therefore, it may be speculated
that these cells could play a role in the occasional spread of MV infection into the
central nervous system.
In the lymph nodes, activated B cells interact with antigen-speciﬁc TH and TFH
cells, resulting in the generation of GC, in which the B cells proliferate and undergo
somatic hypermutation and class-switch recombination. The surviving B cells dif-
ferentiate into either memory B cells or plasma cells and leave the GC. Memory B
cells circulate as resting B cells until reactivation (33, 34). We observed that plasma
cells, class-switched memory B cells, and GC cells were highly susceptible and
permissive to in vitro MV infection. The susceptibility of GC B cells to MV infection
was highlighted in clinical case studies in the 1970s and 1980s, which reported
dramatic improvements in patients with Burkitt’s and Hodgkin’s lymphomas after
infection with wild-type MV. These diseases are associated with Epstein-Barr virus
(EBV) infection (35–37), and some studies have strongly suggested that the malig-
nant cells derive from GC B cells (38, 39). The lymphotropic nature of wild-type MV,
together with the high susceptibility of GC B cells to MV infection, may thus have
contributed to the tumor regression in these patients. The susceptibility of these
malignant cells is also underpinned by the fact that EBV-transformed BLCL are
highly susceptible to MV infection in vitro and have been used for virus production
and reisolation purposes (40). Given that B-cell follicles were depleted in the lymph
nodes of humans and NHPs infected with MV, we speculate that normal human GC
B cells are also highly susceptible and permissive in vivo. The depletion of such an
important subset may hinder the development of plasma and memory B cells. This,
in combination with the partial depletion of preexisting CD150 plasma and
class-switched memory B cells, may result in the restriction of humoral immune
responses to other pathogens after measles and thus contribute to the increased
risk of opportunistic infections and other measles-associated complications.
Differences in the efﬁciency of in vitro MV infection of naive and memory T cells
can largely be explained by their susceptibility, as determined by differences in the
frequency of cells expressing CD150. Interestingly, several B-cell subsets, including
IgG memory and GC B cells, showed high MV infection levels, even though
moderate or low frequencies of these expressed CD150. This suggests that differ-
ences in the efﬁciency of MV infection in lymphocyte subsets are determined not
solely by the expression of CD150 but also by differences in host permissiveness to
viral infection. We speculate that these differences may be related either to
differences in host metabolic activity or to their innate responses to infection.
Further investigations are required to validate these observations. In this study, we
observed on several occasions that the percentage of MV-infected cells was higher
than the percentage of CD150 cells within a speciﬁc lymphocyte subset. We have
previously observed that CD150 expression by PBMC is usually detected as a
continuous gradient, instead of two clearly separated populations of CD150 and
CD150 cells (41). It should be noted that, in the current study, the cutoff for
positivity in the CD150 staining was determined by comparison to an isotype
control staining, and thresholds were always set conservatively. Thus, although the
cells that were deﬁned as CD150 cells are truly positive for CD150 expression, it
cannot be concluded that the remaining cells are all negative for CD150 expression.
Some cells with low levels of CD150 expression that did not reach our cutoff for
positivity could still be susceptible to MV infection.
The susceptibility and permissiveness of naive and memory T and B cells were still
retained when the cells were sorted from the total lymphocyte population, regardless
of their origin from blood or tonsil. This suggests that the susceptibility and permis-
siveness to in vitro MV infection is an inherent characteristic of the cells independent
of the inﬂuence of other cells. We further observed that blood and tonsillar B cells not
only were infected but also could give rise to new infected cells. To what extent the
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infectious virus production by B cells contributes to the systemic dissemination of MV
in vivo remains to be evaluated.
In conclusion, our study has shown that both naive and memory B cells of peripheral
blood and tonsillar origin were susceptible and permissive to MV infection in vitro and
gave rise to newly infected cells, indicating their role as important target cells for MV.
These ﬁndings provide new insights into the pathogenesis of measles and measles-
induced immune suppression.
MATERIALS AND METHODS
Ethics statement. PBMC were obtained from healthy adult donors, and tonsils were obtained from
children undergoing tonsillectomy (Erasmus MC-Sophia Children’s Hospital, Rotterdam, the Netherlands).
Written informed consent was obtained from the donors (for PBMC) or from both parents (for the tonsils),
and the studies were approved by the Medical Ethical Committee of Erasmus MC, Rotterdam, the
Netherlands (MEC-2015-0955 and MEC-2013-093). For experiments involving human buffy coats, written
informed consent for research use was obtained by the Sanquin Blood Bank.
Cells. Human PBMC were isolated from blood (n  10 healthy adult donors) by density gradient
centrifugation. BLCL were established by transformation with Epstein-Barr virus (EBV) as previously
described (42). BLCL were cultured in RPMI 1640 (Lonza, Belgium) supplemented with 10% fetal bovine
serum (FBS; Sigma-Aldrich, USA), 100 IU of penicillin/ml and 100 g of streptomycin/ml (Lonza, Belgium),
and 2 mM L-glutamine (Lonza, Belgium) (R10F medium).
Tonsillar single-cell suspensions were prepared from three different donors as previously described
(43). Cells were pelleted at 500  g for 5 min and resuspended in R10F medium.
African green monkey kidney epithelial Vero cells expressing human CD150 (Vero-CD150) (44) were
grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM; Lonza, Belgium) supplemented with 10% FBS
(Sigma-Aldrich, USA), 100 IU of penicillin/ml and 100 g of streptomycin/ml (Lonza, Belgium), and 2 mM
L-glutamine (Lonza, Belgium).
Viruses. Recombinant MV strain Khartoum-Sudan (KS) expressing the ﬂuorescent reporter protein
Venus from an additional transcription unit in position 3 of the genome [rMVKSVenus(3)] is based on a
wild-type virus isolated from the PBMC of a severe measles patient in Khartoum, Sudan (45). Virus stocks
were generated in BLCL in R10F medium. Wild-type MV strain MVi/Amsterdam.NLD/19.11 (genotype D4)
was isolated from a measles patient in Amsterdam, the Netherlands, in 2011. The virus stock was a
passage 2 isolate grown in Vero-CD150 cells and had a titer of 1.6  106 50% tissue culture infectious
dose (TCID50)/ml (the virus is available via the European Virus Archive). Endpoint titration on Vero-CD150
cells was performed to determine the virus titer, which was expressed as the number of TCID50 per 1 ml
and calculated as described by Reed and Muench (46).
MV infection. Freshly isolated PBMC (2  106 cells) were either cocultured with a low number (2 
104 cells) of autologous rMVKSVenus(3)-infected BLCL or inoculated with cell-free virus at an MOI of 1 in
the presence of 10 g/ml PHCSK4, an infection-enhancing synthetic lipopeptide. The BLCL coculture
model is a dynamic system in which one MV-infected BLCL can infect multiple PBMC by direct cell-to-cell
contact (27). The synthetic cationic lipopeptide PHCSK4 was previously shown to enhance MV binding to
target cells (47). After 30 h, the infection levels of PBMC subsets were determined by ﬂow cytometry.
As no autologous BLCL were available for the tonsil donors, tonsillar lymphocytes (5  105 cells)
were infected with cell-free virus at an MOI of 1 in the presence of infection-enhancing lipopeptide as
described above. Infection levels were determined by ﬂow cytometry after 24 h.
Cell sorting. PBMC isolated from buffy coats were enriched for B cells by partial depletion of CD14
monocytes and CD3 T cells using MicroBeads (Miltenyi Biotec). Subsequently, four lymphocyte subsets
were sorted from the partially enriched PBMC or tonsils using a BD FACSAria II cell sorter (BD Biosciences):
the remaining CD4 naive and memory T cells and naive and memory B cells. Complete lymphocyte
subset deﬁnitions are listed in Table 2. The sorted cells were inoculated with cell-free rMVKSVenus(3) at
an MOI of 3 in the presence of infection-enhancing lipopeptide. Infection levels were determined by ﬂow
cytometry after 24 h, and the numbers of productively MV-infected cells were determined by infectious
center assay.
Flow cytometry. T cells were divided into four main subsets: naive T cells, central memory T cells
(TCM), CD45RA effector memory cells (TEMRO), and CD45RA effector memory cells (TEMRA). B cells were
divided into four main subsets: naive B cells, non-class-switched IgM memory B cells, CD27 IgM
class-switched memory cells, and CD27 IgM class-switched memory cells. Memory T and B cells were
further subdivided into different speciﬁc subsets. Complete lymphocyte subset deﬁnitions are listed in
Table 1. Flow cytometry was performed using a Fortessa cell analyzer or a BD FACSCanto II ﬂow
cytometer (BD Biosciences). The antibodies used in this experiment are listed in Table 3. The threshold
for CD150 positivity was determined by using a ﬂuorescein isothiocyanate (FITC)-conjugated isotype
control: the histogram gate of the isotype background signal was set at 1% and this percentage was
subsequently subtracted from the percentage of CD150 cells. For sorted naive and memory CD4 T and
B cells, the cells were stained prior to sorting with the antibodies listed in Table 3. The infection levels
were determined by detection of the Venus ﬂuorescent signal or detection of intracellular MV NP within
every lymphocyte subset. Cells infected with wild-type MV were ﬁxed and permeabilized with a BD
Cytoﬁx/Cytoperm ﬁxation and permeabilization kit according to the manufacturer’s instructions (BD
Biosciences), and the presence of MV NP was determined by intracellular staining with an FITC-
conjugated monoclonal MV NP antibody (catalog number MAB8906F; Merck Millipore, USA). Infected
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cells were ﬁxed with 2% paraformaldehyde prior to FACS measurement. Data were acquired with BD
FACSDiva software and analyzed with FlowJo software.
Infectious center assay. Serial 2-fold dilutions of MV-infected sorted naive or memory lymphocytes
were cocultured with BLCL (2 104 cells/well) in a 96-well round-bottomed plate as described previously
(48). The ﬂuorescent signal was monitored by UV microscopy after 6 days. The numbers of MV-infected
cells were calculated as 50% endpoints using the formula of Reed and Muench (46).
Statistical analysis. Differences between the percentages of CD150 or infected cells were analyzed
by a paired t test or the Wilcoxon signed-rank test.
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TABLE 3 Flow cytometry antibody and cell-sorting antibody details
Assay and antigen Antibody clone Fluorochromea Manufacturer
Flow cytometry
CD27 M-T271 BV421 BD Biosciences
IgM MHM-88 BV510 BioLegend
CD38 HIT2 BV605 BioLegend
IgD IA6-2 PerCP-Cy5.5 BioLegend
IgA IS11-8E10 PE Miltenyi Biotech
IgG G18-145 PE-CF594 BD Biosciences
CD19 J3-119 PC7 Beckman Coulter
CD21 B-ly4 APC BD Biosciences
CD24 ALB9 APC-AF750 Beckman Coulter
CD4 OKT4 BV510 BioLegend
CD45RA HI100 BV605 BioLegend
CD28 CD28.2 PerCP-Cy5.5 BioLegend
CD3 SK7 PE BD Biosciences
CCR7 150503 PE-CF594 BD Biosciences
TCR 11F2 PE-Cy7 BD Biosciences
CXCR5 51505 APC R&D Systems
CD8 SK1 APC-H7 BD Biosciences
CD25 BC96 BV421 BioLegend
CXCR3 1C6 BV711 BD Biosciences
CCR6 G034E3 PerCP-Cy5.5 BioLegend
CCR4 L291H4 PE-Cy7 BioLegend
CD127 A019D5 APC BioLegend
CD150 A12 FITC AbD Serotec
MV nucleoprotein 83KKII FITC Merck Millipore
Isotype CLB-203 FITC BD Biosciences
Cell sorting
CD19 J3-119 PC7 Beckman Coulter
CD38 HIT-2 BV605 BioLegend
CD27 M-T271 BV421 BD Biosciences
IgM MHM-88 BV510 BioLegend
CD3 UCHT1 PE BD Biosciences
CCR7 150503 PE-CF594 BD Biosciences
CD8 SK1 APC-H7 BD Biosciences
CD4 RPA-T4 APC BD Biosciences
CD45RO UCHL1 FITC eBioscience
aPerCP, peridinin chlorophyll protein; PE, phycoerythrin; APC, allophycocyanin; FITC, ﬂuorescein
isothiocyanate; BV, Brilliant violet; AF, Alexa Fluor.
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